| Absorption |
| Blood-Brain Barrier | BBB+ | 0.9778 |
| Human Intestinal Absorption | HIA+ | 1.0000 |
| Caco-2 Permeability | Caco2+ | 0.7535 |
| P-glycoprotein Substrate | Non-substrate | 0.6750 |
| P-glycoprotein Inhibitor | Inhibitor | 0.8106 |
| Inhibitor | 0.5156 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.5059 |
| Distribution |
| Subcellular localization | Mitochondria | 0.5513 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.8530 |
| CYP450 2D6 Substrate | Substrate | 0.8919 |
| CYP450 3A4 Substrate | Non-substrate | 0.5776 |
| CYP450 1A2 Inhibitor | Inhibitor | 0.8745 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.7122 |
| CYP450 2D6 Inhibitor | Inhibitor | 0.6340 |
| CYP450 2C19 Inhibitor | Inhibitor | 0.8499 |
| CYP450 3A4 Inhibitor | Inhibitor | 0.6346 |
| CYP Inhibitory Promiscuity | High CYP Inhibitory Promiscuity | 0.8823 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.6152 |
| Inhibitor | 0.8112 |
| AMES Toxicity | Non AMES toxic | 0.5993 |
| Carcinogens | Non-carcinogens | 0.7532 |
| Fish Toxicity | High FHMT | 0.8509 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.9757 |
| Honey Bee Toxicity | High HBT | 0.6195 |
| Biodegradation | Not ready biodegradable | 0.9893 |
| Acute Oral Toxicity | III | 0.7094 |
| Carcinogenicity (Three-class) | Non-required | 0.5992 |